APTO
Income statement / Annual
Last year (2024), Aptose Biosciences Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Aptose Biosciences Inc.'s net income was -$25.43 M.
See Aptose Biosciences Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$474,545.00
|
$507,079.00
|
$616,527.00
|
$646,435.00
|
$627,251.00
|
$83,512.00
|
$89,092.00
|
$114,835.00
|
$69,109.00
|
| Gross Profit |
$0.00
|
-$474,545.00
|
-$507,079.00
|
-$616,527.00
|
-$646,435.00
|
-$627,251.00
|
-$83,512.00
|
-$89,092.00
|
-$114,835.00
|
-$69,109.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$15.10 M
|
$36.77 M
|
$28.09 M
|
$45.99 M
|
$29.29 M
|
$16.84 M
|
$18.73 M
|
$6.27 M
|
$7.66 M
|
$4.48 M
|
| General & Administrative Expenses |
$11.15 M
|
$15.59 M
|
$14.51 M
|
$19.46 M
|
$26.48 M
|
$10.02 M
|
$10.37 M
|
$5.50 M
|
$6.13 M
|
$7.05 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$53,000.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$11.15 M
|
$15.59 M
|
$14.51 M
|
$19.46 M
|
$26.48 M
|
$10.02 M
|
$10.37 M
|
$5.50 M
|
$6.13 M
|
$7.05 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$26.26 M
|
$52.36 M
|
$42.60 M
|
$65.45 M
|
$55.77 M
|
$26.86 M
|
$29.11 M
|
$11.83 M
|
$13.80 M
|
$11.52 M
|
| Cost And Expenses |
$0.00
|
$52.36 M
|
$42.60 M
|
$65.45 M
|
$55.77 M
|
$26.86 M
|
$29.11 M
|
$11.83 M
|
$13.92 M
|
$11.59 M
|
| Interest Income |
$357,000.00
|
$1.15 M
|
$788,000.00
|
$94,000.00
|
$522,000.00
|
$574,000.00
|
$283,000.00
|
$165,000.00
|
$78,119.00
|
$205,888.00
|
| Interest Expense |
-$207,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$49,103.00
|
$30,986.00
|
| Depreciation & Amortization |
$0.00
|
$88,000.00
|
$120,000.00
|
$150,000.00
|
$646,435.00
|
$613,000.00
|
$83,512.00
|
$89,092.00
|
$114,835.00
|
$69,109.00
|
| EBITDA |
$0.00 |
-$52.27 M |
-$42.48 M |
-$65.30 M |
-$55.62 M |
-$26.26 M |
-$29.02 M |
-$11.74 M |
-$13.78 M |
-$10.43 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$0.00
|
$1.15 M
|
$779,000.00
|
$93,000.00
|
$530,000.00
|
$580,000.00
|
$239,000.00
|
$165,000.00
|
$29,015.00
|
$1.06 M
|
| Income Before Tax |
-$25.43 M
|
-$51.21 M
|
-$41.82 M
|
-$65.35 M
|
-$55.24 M
|
-$26.28 M
|
-$28.87 M
|
-$11.66 M
|
-$13.86 M
|
-$10.54 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$18,000.00
|
$31,518.00
|
$30,986.00
|
| Net Income |
-$25.43 M
|
-$51.21 M
|
-$41.82 M
|
-$65.35 M
|
-$55.24 M
|
-$26.28 M
|
-$28.87 M
|
-$11.66 M
|
-$13.86 M
|
-$10.54 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.0364 |
-7.58 |
-6.67 |
-10.99 |
-10.03 |
-7.8 |
-12.97 |
-7.84 |
-16.32 |
-13.29 |
| EPS Diluted |
-0.0364 |
-7.58 |
-6.67 |
-10.99 |
-10.03 |
-7.8 |
-12.97 |
-7.84 |
-16.31 |
-13.28 |
| Weighted Average Shares Out |
$698.98 M
|
$6.76 M
|
$6.15 M
|
$5.94 M
|
$181,000.00
|
$3.34 M
|
$2.23 M
|
$1.49 M
|
$849,533.00
|
$793,733.00
|
| Weighted Average Shares Out Diluted |
$698.98 M
|
$6.76 M
|
$6.15 M
|
$5.94 M
|
$181,859.00
|
$3.34 M
|
$2.23 M
|
$1.49 M
|
$849,533.00
|
$793,733.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
